Literature DB >> 25559689

Grading glial tumors with amide proton transfer MR imaging: different analytical approaches.

Akihiko Sakata1, Tomohisa Okada, Akira Yamamoto, Mitsunori Kanagaki, Yasutaka Fushimi, Tsutomu Okada, Toshiki Dodo, Yoshiki Arakawa, Benjamin Schmitt, Susumu Miyamoto, Kaori Togashi.   

Abstract

Amide proton transfer (APT) magnetic resonance imaging is gaining attention for its capability for grading glial tumors. Usually, a representative slice is analyzed. Different definitions of tumor areas have been employed in previous studies. We hypothesized that the accuracy of APT imaging for brain tumor grading may depend upon the analytical methodology used, such as selection of regions of interest (ROIs), single or multiple tumor slices, and whether or not there is normalization to the contralateral white matter. This study was approved by the institutional review board, and written informed consent was waived. Twenty-six patients with histologically proven glial tumors underwent preoperative APT imaging with a three-dimensional gradient-echo sequence. Two neuroradiologists independently analyzed APT asymmetry (APTasym) images by placing ROIs on both a single representative slice (RS) and all slices including tumor (i.e. whole tumor: WT). ROIs indicating tumor extent were separately defined on both FLAIR and, if applicable, contrast-enhanced T1-weighted images (CE-T1WI), yielding four mean APTasym values (RS-FLAIR, WT-FLAIR, RS-CE-T1WI, and WT-CE-T1WI). The maximum values were also measured using small ROIs, and their differences among grades were evaluated. Receiver operating characteristic (ROC) curve analysis was also conducted on mean and maximum values. Intra-class correlation coefficients for inter-observer agreement were excellent. Significant differences were observed between high- and low-grade gliomas for all five methods (P < 0.01). ROC curve analysis found no statistically significant difference among them. This study clarifies that single-slice APT analysis is robust despite tumor heterogeneity, and can grade glial tumors with or without the use of contrast material.

Entities:  

Mesh:

Year:  2015        PMID: 25559689     DOI: 10.1007/s11060-014-1715-8

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  37 in total

1.  Usefulness of diffusion-weighted MRI with echo-planar technique in the evaluation of cellularity in gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; Y Shigematu; T Hirai; T Okuda; L Liang; Y Ge; Y Komohara; Y Ushio; M Takahashi
Journal:  J Magn Reson Imaging       Date:  1999-01       Impact factor: 4.813

Review 2.  Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.

Authors:  A Dean Sherry; Mark Woods
Journal:  Annu Rev Biomed Eng       Date:  2008       Impact factor: 9.590

3.  Amide proton transfer imaging of human brain tumors at 3T.

Authors:  Craig K Jones; Michael J Schlosser; Peter C M van Zijl; Martin G Pomper; Xavier Golay; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2006-09       Impact factor: 4.668

4.  7 Tesla imaging of cerebral radiation necrosis after arteriovenous malformations treatment using amide proton transfer (APT) imaging.

Authors:  Lars Gerigk; Benjamin Schmitt; Bram Stieltjes; Falk Röder; Marco Essig; Michael Bock; Heinz-Peter Schlemmer; Matthias Röthke
Journal:  J Magn Reson Imaging       Date:  2012-01-13       Impact factor: 4.813

5.  MR imaging of high-grade brain tumors using endogenous protein and peptide-based contrast.

Authors:  Zhibo Wen; Shuguang Hu; Fanheng Huang; Xianlong Wang; Linglang Guo; Xianyue Quan; Silun Wang; Jinyuan Zhou
Journal:  Neuroimage       Date:  2010-02-24       Impact factor: 6.556

6.  Chemical exchange saturation transfer (CEST): what is in a name and what isn't?

Authors:  Peter C M van Zijl; Nirbhay N Yadav
Journal:  Magn Reson Med       Date:  2011-02-17       Impact factor: 4.668

7.  Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response.

Authors:  Adrienne N Dula; Lori R Arlinghaus; Richard D Dortch; Blake E Dewey; Jennifer G Whisenant; Gregory D Ayers; Thomas E Yankeelov; Seth A Smith
Journal:  Magn Reson Med       Date:  2012-08-20       Impact factor: 4.668

8.  Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing.

Authors:  Shipra Agarwal; Mehar Chand Sharma; Prerana Jha; Pankaj Pathak; Vaishali Suri; Chitra Sarkar; Kunzang Chosdol; Ashish Suri; Shashank Sharad Kale; Ashok Kumar Mahapatra; Pankaj Jha
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

9.  Magnetic resonance image-guided proteomics of human glioblastoma multiforme.

Authors:  Susan K Hobbs; Gongyi Shi; Ron Homer; Griff Harsh; Scott W Atlas; Mark D Bednarski
Journal:  J Magn Reson Imaging       Date:  2003-11       Impact factor: 4.813

10.  Nuclear overhauser enhancement mediated chemical exchange saturation transfer imaging at 7 Tesla in glioblastoma patients.

Authors:  Daniel Paech; Moritz Zaiss; Jan-Eric Meissner; Johannes Windschuh; Benedikt Wiestler; Peter Bachert; Jan Oliver Neumann; Philipp Kickingereder; Heinz-Peter Schlemmer; Wolfgang Wick; Armin Michael Nagel; Sabine Heiland; Mark Edward Ladd; Martin Bendszus; Alexander Radbruch
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

View more
  34 in total

1.  Evaluating the Role of Amide Proton Transfer (APT)-Weighted Contrast, Optimized for Normalization and Region of Interest Selection, in Differentiation of Neoplastic and Infective Mass Lesions on 3T MRI.

Authors:  Ayan Debnath; Rakesh Kumar Gupta; Anup Singh
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.

Authors:  Shanshan Jiang; Tianyu Zou; Charles G Eberhart; Maria A V Villalobos; Hye-Young Heo; Yi Zhang; Yu Wang; Xianlong Wang; Hao Yu; Yongxing Du; Peter C M van Zijl; Zhibo Wen; Jinyuan Zhou
Journal:  Magn Reson Med       Date:  2017-07-16       Impact factor: 4.668

3.  Relaxation-compensated amide proton transfer (APT) MRI signal intensity is associated with survival and progression in high-grade glioma patients.

Authors:  Daniel Paech; Constantin Dreher; Sebastian Regnery; Jan-Eric Meissner; Steffen Goerke; Johannes Windschuh; Johanna Oberhollenzer; Miriam Schultheiss; Katerina Deike-Hofmann; Sebastian Bickelhaupt; Alexander Radbruch; Moritz Zaiss; Andreas Unterberg; Wolfgang Wick; Martin Bendszus; Peter Bachert; Mark E Ladd; Heinz-Peter Schlemmer
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

4.  Amide proton transfer-weighted magnetic resonance image-guided stereotactic biopsy in patients with newly diagnosed gliomas.

Authors:  Shanshan Jiang; Charles G Eberhart; Yi Zhang; Hye-Young Heo; Zhibo Wen; Lindsay Blair; Huamin Qin; Michael Lim; Alfredo Quinones-Hinojosa; Jon D Weingart; Peter B Barker; Martin G Pomper; John Laterra; Peter C M van Zijl; Jaishri O Blakeley; Jinyuan Zhou
Journal:  Eur J Cancer       Date:  2017-07-10       Impact factor: 9.162

5.  Applying protein-based amide proton transfer MR imaging to distinguish solitary brain metastases from glioblastoma.

Authors:  Hao Yu; Huiling Lou; Tianyu Zou; Xianlong Wang; Shanshan Jiang; Zhongqing Huang; Yongxing Du; Chunxiu Jiang; Ling Ma; Jianbin Zhu; Wen He; Qihong Rui; Jianyuan Zhou; Zhibo Wen
Journal:  Eur Radiol       Date:  2017-05-22       Impact factor: 5.315

6.  Applying amide proton transfer-weighted MRI to distinguish pseudoprogression from true progression in malignant gliomas.

Authors:  Bo Ma; Jaishri O Blakeley; Xiaohua Hong; Hongyan Zhang; Shanshan Jiang; Lindsay Blair; Yi Zhang; Hye-Young Heo; Mingzhi Zhang; Peter C M van Zijl; Jinyuan Zhou
Journal:  J Magn Reson Imaging       Date:  2016-01-20       Impact factor: 4.813

7.  Direct saturation-corrected chemical exchange saturation transfer MRI of glioma: Simplified decoupling of amide proton transfer and nuclear overhauser effect contrasts.

Authors:  Iris Yuwen Zhou; Enfeng Wang; Jerry S Cheung; Dongshuang Lu; Yang Ji; Xiaoan Zhang; Giulia Fulci; Phillip Zhe Sun
Journal:  Magn Reson Med       Date:  2017-10-13       Impact factor: 4.668

8.  Amide Proton Transfer Imaging Allows Detection of Glioma Grades and Tumor Proliferation: Comparison with Ki-67 Expression and Proton MR Spectroscopy Imaging.

Authors:  C Su; C Liu; L Zhao; J Jiang; J Zhang; S Li; W Zhu; J Wang
Journal:  AJNR Am J Neuroradiol       Date:  2017-07-20       Impact factor: 3.825

Review 9.  Magnetization Transfer Contrast and Chemical Exchange Saturation Transfer MRI. Features and analysis of the field-dependent saturation spectrum.

Authors:  Peter C M van Zijl; Wilfred W Lam; Jiadi Xu; Linda Knutsson; Greg J Stanisz
Journal:  Neuroimage       Date:  2017-04-21       Impact factor: 6.556

10.  Histogram analysis of amide proton transfer-weighted imaging: comparison of glioblastoma and solitary brain metastasis in enhancing tumors and peritumoral regions.

Authors:  Kiyohisa Kamimura; Masanori Nakajo; Tomohide Yoneyama; Yoshihiko Fukukura; Hirofumi Hirano; Yuko Goto; Masashi Sasaki; Yuta Akamine; Jochen Keupp; Takashi Yoshiura
Journal:  Eur Radiol       Date:  2018-11-28       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.